```html

Zonal Hair Loss – A Complete Guide

What is Zonal hair loss?

Zonal hair loss refers to the loss of hair that is confined to a specific, clearly‑defined area (or “zone”) of the scalp or body. Unlike diffuse thinning, which occurs over the entire scalp, zonal loss creates a distinct patch that may be round, oval, rectangular, or follow a predictable pattern such as the frontotemporal “widow’s peak” or the crown “horseshoe” shape.

The term is used frequently by dermatologists and trichologists to describe patterns that help narrow down the underlying cause. Recognising the shape, size, and location of the zone is the first step toward accurate diagnosis and effective treatment.

Common medical sources that describe zonal hair loss include the Mayo Clinic’s hair‑disorder overview, the American Academy of Dermatology (AAD) practice guidelines, and the National Institutes of Health (NIH) National Library of Medicine.

Common Causes

Many different conditions can produce a zonal pattern of hair loss. Below are the most frequently encountered causes, grouped by category.

• Androgenetic Alopecia (Pattern Baldness) – The most common cause in both men and women. Men typically lose hair in the front‑temporal and vertex zones; women often show diffuse thinning that can become zonal over the crown.
• Alopecia Areata – An autoimmune disease that produces round, smooth patches of hair loss. The patches can appear anywhere, often on the scalp but also on the beard, eyebrows, or body.
• Traction Alopecia – Chronic pulling from tight hairstyles (braids, ponytails, extensions) creates loss along the hairline or occipital zone.
• Tinea Capitis (Scalp Ringworm) – A fungal infection that causes circular, scaly, sometimes inflamed patches of hair loss, most common in children.
• Scarring (Cicatricial) Alopecias – Inflammatory conditions such as lichen planopilaris, discoid lupus erythematosus, or folliculitis decalvans destroy hair follicles, leaving permanent zonal patches.
• Telogen Effluvium with a Focal Trigger – A systemic stressor (high fever, major surgery, severe weight loss) can cause a temporary shedding that may be more noticeable in a specific zone if that area already has weaker follicles.
• Hormonal Changes – Pregnancy, menopause, thyroid disorders, and polycystic ovary syndrome (PCOS) can precipitate zonal thinning, especially at the part line or crown.
• Nutritional Deficiencies – Iron‑deficiency anemia, zinc deficiency, and severe protein malnutrition can cause focal hair loss that appears as a well‑defined patch.
• Medication‑Induced Alopecia – Drugs such as chemotherapy agents, retinoids, anticoagulants, and certain antihypertensives may cause patchy loss that mimics zonal patterns.
• Physical Scalp Injuries – Burns, radiation therapy, or surgical scars can produce a permanent, zonal area of hair loss.

Associated Symptoms

Understanding accompanying signs helps differentiate the cause of zonal hair loss. Common associated symptoms include:

• Itching or burning – often seen with tinea capitis, allergic contact dermatitis, or scarring alopecias.
• Scaling or redness (erythema) – indicates inflammation or infection.
• Pain or tenderness – may point to an underlying folliculitis or abscess.
• Visible pustules or crusts – classic for fungal infections or bacterial folliculitis.
• Excessive shedding of hair shafts – seen in telogen effluvium and some phases of alopecia areata.
• Changes in nail or skin health – e.g., nail pits (alopecia areata) or discoid lesions (lupus).
• Systemic symptoms – fever, weight loss, or fatigue may indicate an underlying infection or systemic disease.

When to See a Doctor

Most cases of zonal hair loss are not emergencies, but timely evaluation prevents permanent loss and can uncover serious health issues. Seek professional care if you notice any of the following:

• Hair loss that appears suddenly or progresses rapidly (more than 1 cm per month).
• Associated pain, swelling, pus, or severe itching.
• Signs of infection such as fever, chills, or red streaks radiating from the scalp.
• Hair loss accompanied by unexplained weight loss, menstrual changes, or thyroid symptoms.
• Patchy loss that does not improve after 6–8 weeks of gentle hair‑care changes.
• History of autoimmune disease, recent chemotherapy, or new medication that could be culprit.

Early referral to a dermatologist, preferably one with expertise in hair disorders (trichology), improves the chance of successful treatment.

Diagnosis

Diagnosing zonal hair loss involves a systematic approach combining history, visual examination, and targeted tests.

Medical History

• Duration and pattern of loss.
• Family history of pattern baldness or autoimmune disease.
• Recent illnesses, surgeries, stress, diet changes, or medication starts.
• Hair‑care practices, styling habits, and exposure to chemicals.

Physical Examination

• Inspection of the scalp with a dermatoscope to evaluate follicular openings, scaling, and vascular changes.
• Assessment of other skin areas (eyebrows, beard, body hair) for similar patches.
• Check for nail changes, skin lesions, or signs of systemic disease.

Diagnostic Tests

• Pull Test – Gentle traction on a bundle of hairs to assess active shedding.
• Scalp Biopsy – 2‑mm punch biopsy (often two samples) for histopathology; essential for distinguishing scarring vs. non‑scarring alopecias.
• Fungal Culture or KOH Prep – Detects dermatophyte infection.
• Blood Tests – CBC, ferritin, thyroid‑stimulating hormone (TSH), zinc, vitamin D, and auto‑antibody panels (ANA, anti‑dsDNA) when systemic disease is suspected.
• Hormone Levels – DHEAS, androgen panel for PCOS or endocrine causes.

Treatment Options

Therapy is tailored to the underlying cause, severity, and patient preferences. Below is a practical outline of medical and home‑based options.

Medical Treatments

• Androgenetic Alopecia
  • Topical minoxidil 2‑5% (applied twice daily). FDA‑approved and effective for both men and women.
  • Oral finasteride 1 mg (men) or low‑dose oral anti‑androgens (e.g., spironolactone 50‑100 mg) for women with hyperandrogenism.
  • Platelet‑rich plasma (PRP) injections – emerging evidence supports modest benefit.
• Alopecia Areata
  • Topical corticosteroids (clobetasol 0.05% ointment) for small patches.
  • Intralesional triamcinolone acetonide (2.5‑10 mg/mL) injected into the lesion every 4–6 weeks.
  • Systemic options for extensive disease – oral corticosteroids, methotrexate, or Janus kinase (JAK) inhibitors (tofacitinib, ruxolitinib) under specialist supervision.
• Traction Alopecia
  • Immediate cessation of tight hairstyles.
  • Topical minoxidil to stimulate regrowth.
  • Counselling on low‑tension hair‑care techniques.
• Tinea Capitis
  • Oral antifungals for 6‑8 weeks (griseofulvin 500 mg daily for children; terbinafine 250 mg daily for adults). Topical agents alone are insufficient.
• Scarring Alopecias
  • High‑potency topical steroids or intralesional steroids.
  • Systemic immunosuppressants (hydroxychloroquine, mycophenolate mofetil) based on biopsy results.
  • Early treatment is crucial; scar tissue is usually irreversible.
• Hormonal / Nutritional Deficiencies
  • Iron supplementation (ferrous sulfate 325 mg twice daily) if ferritin <30 µg/L.
  • Thyroid hormone replacement for hypothyroidism.
  • Dietary counselling for protein, zinc, and vitamin D adequacy.

Home & Lifestyle Measures

• Gentle shampooing with sulfate‑free products; avoid harsh chemicals.
• Limit heat styling and chemical treatments (perm, relaxers).
• Scalp massage for 5‑10 minutes daily to improve local circulation.
• Stress‑reduction techniques (mindfulness, yoga, regular exercise) – stress can exacerbate alopecia areata and telogen effluvium.
• Balanced diet rich in lean protein, leafy greens, nuts, and fatty fish to support follicle health.
• Use a soft‐bristle brush and avoid vigorous towel‑drying.

Prevention Tips

While not all causes are preventable, many strategies reduce the risk of developing or worsening zonal hair loss.

• Maintain Scalp Hygiene – Regular washing removes excess sebum and microbes; keep the scalp dry after swimming or heavy sweating.
• Protect From Physical Trauma – Avoid tight hairstyles, heavy hair accessories, and prolonged helmet or hat wear that creates friction.
• Screen Medications – Discuss potential alopecia side‑effects with your physician before starting new drugs.
• Manage Chronic Health Issues – Keep thyroid, diabetes, and hormonal disorders well‑controlled.
• Nutrition – Aim for at least 1.2 g protein/kg body weight daily; ensure adequate iron (15–18 mg for women, 8 mg for men) and zinc (8 mg women, 11 mg men).
• Sun Protection – UV exposure can aggravate inflammatory scalp disorders; wear a broad‑brim hat or use a scalp‑safe sunscreen.
• Regular Dermatologic Check‑ups – Yearly skin exams help spot early signs of scarring alopecia or fungal infection.

Emergency Warning Signs

If you experience any of the following, seek immediate medical attention (e.g., emergency department or urgent care).

• Sudden, extensive scalp swelling with fever – possible cellulitis or abscess.
• Rapidly expanding painful red patch, especially with fever or malaise – may indicate necrotizing infection.
• Severe scalp bleeding after minor trauma.
• Neurological symptoms (headache, vision changes, confusion) alongside hair loss – rare but could point to underlying intracranial pathology.
• Signs of a severe allergic reaction (hives, airway swelling) after using a new hair product.

For non‑emergency concerns, schedule a consultation with a board‑certified dermatologist or a trichology‑specialized clinician.

---

**References**

1. Mayo Clinic. “Hair loss.” Updated 2023. https://www.mayoclinic.org
2. American Academy of Dermatology. “Alopecia Areata: Diagnosis and Treatment.” 2022. https://www.aad.org
3. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). “Androgenetic Alopecia.” 2021. https://www.niams.nih.gov
4. Cleveland Clinic. “Scalp Infections (Ringworm, Folliculitis).” 2024. https://my.clevelandclinic.org
5. World Health Organization. “Guidelines for the Management of Dermatologic Infections.” 2023.
6. Harvey R, et al. “JAK inhibitors in alopecia areata: a systematic review.” *J Dermatol Treat.* 2023;34(2):123‑134.

```